PlasmaTech Biopharma (PTBI) Posts Markedly Better Q1 Results
Tweet
Share
E-mailGet Alerts PTBI Hot Sheet
Join SI Premium – FREE
PlasmaTech Biopharma (NASDAQ: PTBI) reported Q1 EPS of ($0.10), versus ($3.06) reported last year. Revenue for the quarter came in at $258 thousand, versus $208 thousand reported last year.
For earnings history and earnings-related data on PlasmaTech Biopharma (PTBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
